Treatment of tumor-bearing WT mice with oxaliplatin was associated with emergence of a tumor-infiltrating CD19+CD138+IgA+ plasma cell population that expressed IL-10, PD-L1, phosphorylated Stat3, and Fas-L. This evidence concerns the gene CD274 and neoplasm.